Evidence map›Paper›PMID 30389718›Full record

ArticleCancer immunology research2018

Of Microbes and Microsatellites.

Chloe E Atreya, Alan P Venook

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Comment on
    2018
5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chloe E AtreyaDepartment of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. chloe.atreya@ucsf.edu.
Alan P VenookDepartment of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
UCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer ModelsK08CA175153 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ATREYA, CHLOE E. · 2013 to 2017
$867k
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomesR21CA227232 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ATREYA, CHLOE E., TURNBAUGH, PETER JAMES · 2018 to 2019
$378k
NCI NIH HHS K08 CA175153NCI NIH HHS R21 CA227232
6 · The paper itself

Abstract

A ubiquitous oral cavity microbe,

Indexed as

Microsatellite InstabilityColorectal NeoplasmsFusobacterium nucleatumHumansLymphocytes, Tumor-InfiltratingMicrosatellite Repeats

Identifiers

PMID30389718
OpenAlexW2904725729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.